Related Experiment Video
Updated: Aug 21, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Hemorrhagic complications of piperacillin therapy
Abstract:
Clinically significant hemorrhage associated with extended spectrum anti-Pseudomonas penicillins is uncommon. We describe 2 patients with bleeding complications owing to piperacillin. In addition, we review the incidence and mechanism of this adverse reaction, and make suggestions for the management of these patients.
Insights
Hemorrhage from extended spectrum anti-Pseudomonas penicillins like piperacillin is rare. This report details two cases of piperacillin-induced bleeding and discusses its incidence, mechanism, and management.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Extended spectrum anti-Pseudomonas penicillins are crucial in treating severe infections.
- Clinically significant hemorrhage is an uncommon but serious adverse effect associated with these antibiotics.
Observation:
- Two patients experienced bleeding complications attributed to piperacillin therapy.
- These cases highlight a potential, albeit infrequent, risk of this antibiotic class.
Findings:
- The incidence and underlying mechanisms of piperacillin-induced bleeding were reviewed.
- Piperacillin, like other extended spectrum penicillins, may interfere with hemostasis.
Implications:
- Awareness of this adverse reaction is important for clinicians.
- Management strategies for patients experiencing hemorrhage during piperacillin treatment are suggested.
Related Concept Videos
Endocarditis IV: Nursing Management
Aneurysm III: Interprofessional Care
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pancreatitis II: Pathophysiology

